Nitric oxide synthases: regulation and function U Förstermann, WC Sessa European heart journal 33 (7), 829-837, 2012 | 4831 | 2012 |
Endothelial nitric oxide synthase in vascular disease: from marvel to menace U Forstermann, T Münzel Circulation 113 (13), 1708-1714, 2006 | 2636 | 2006 |
Nitric oxide synthase isozymes. Characterization, purification, molecular cloning, and functions. U Förstermann, EI Closs, JS Pollock, M Nakane, P Schwarz, I Gath, ... Hypertension 23 (6_pt_2), 1121-1131, 1994 | 1704 | 1994 |
Mechanisms underlying endothelial dysfunction in diabetes mellitus U Hink, H Li, H Mollnau, M Oelze, E Matheis, M Hartmann, M Skatchkov, ... Circulation research 88 (2), e14-e22, 2001 | 1558 | 2001 |
Roles of vascular oxidative stress and nitric oxide in the pathogenesis of atherosclerosis U Förstermann, N Xia, H Li Circulation research 120 (4), 713-735, 2017 | 1300 | 2017 |
Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells. JS Pollock, U Förstermann, JA Mitchell, TD Warner, HH Schmidt, ... Proceedings of the National Academy of Sciences 88 (23), 10480-10484, 1991 | 1259 | 1991 |
Isoforms of nitric oxide synthase characterization and purification from different cell types U Förstermann, HHHW Schmidt, JS Pollock, H Sheng, JA Mitchell, ... Biochemical pharmacology 42 (10), 1849-1857, 1991 | 1164 | 1991 |
Nitric oxide and oxidative stress in vascular disease U Förstermann Pflügers Archiv-European Journal of Physiology 459, 923-939, 2010 | 1021 | 2010 |
Nitric oxide in the pathogenesis of vascular disease H Li, U Förstermann The Journal of pathology 190 (3), 244-254, 2000 | 1020 | 2000 |
Expressional control of the ‘constitutive’isoforms of nitric oxide synthase (NOS I and NOS III) U Förstermann, JP Boissel, H Kleinert The FASEB Journal 12 (10), 773-790, 1998 | 922 | 1998 |
Effects of angiotensin II infusion on the expression and function of NAD (P) H oxidase and components of nitric oxide/cGMP signaling H Mollnau, M Wendt, K Szöcs, B Lassègue, E Schulz, M Oelze, H Li, ... Circulation research 90 (4), e58-e65, 2002 | 880 | 2002 |
Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase T Wallerath, G Deckert, T Ternes, H Anderson, H Li, K Witte, ... Circulation 106 (13), 1652-1658, 2002 | 870 | 2002 |
Vascular oxidative stress, nitric oxide and atherosclerosis H Li, S Horke, U Förstermann Atherosclerosis 237 (1), 208-219, 2014 | 787 | 2014 |
Calmodulin-dependent endothelium-derived relaxing factor/nitric oxide synthase activity is present in the particulate and cytosolic fractions of bovine aortic endothelial cells. U Förstermann, JS Pollock, HH Schmidt, M Heller, F Murad Proceedings of the National Academy of Sciences 88 (5), 1788-1792, 1991 | 786 | 1991 |
Cloned human brain nitric oxide synthase is highly expressed in skeletal muscle M Nakane, HHHW Schmidt, JS Pollock, U Förstermann, F Murad FEBS letters 316 (2), 175-180, 1993 | 741 | 1993 |
Oxidative stress in vascular disease: causes, defense mechanisms and potential therapies U Förstermann Nature clinical practice Cardiovascular medicine 5 (6), 338-349, 2008 | 691 | 2008 |
Nitric oxide synthase: expression and expressional control of the three isoforms U Förstermann, H Kleinert Naunyn-Schmiedeberg's archives of pharmacology 352, 351-364, 1995 | 657 | 1995 |
Allgemeine und spezielle Pharmakologie und Toxikologie K Aktories, U Förstermann, F Hofmann, K Starke Elsevier, 2017 | 645 | 2017 |
Selective attenuation of endothelium-mediated vasodilation in atherosclerotic human coronary arteries. U Förstermann, A Mügge, U Alheid, A Haverich, JC Frölich Circulation research 62 (2), 185-190, 1988 | 606 | 1988 |
Antioxidant effects of resveratrol in the cardiovascular system N Xia, A Daiber, U Förstermann, H Li British journal of pharmacology 174 (12), 1633-1646, 2017 | 557 | 2017 |